KEGG   PATHWAY: mdo04012Help
Entry
mdo04012                    Pathway                                

Name
ErbB signaling pathway - Monodelphis domestica (opossum)
Description
The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, differentiation, cell motility, and survival. Ligand binding to the four closely related members of this RTK family -epidermal growth factor receptor (EGFR, also known as ErbB-1 or HER1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4)-induces the formation of receptor homo- and heterodimers and the activation of the intrinsic kinase domain, resulting in phosphorylation on specific tyrosine residues (pY) within the cytoplasmic tail. Signaling effectors containing binding pockets for pY-containing peptides are recruited to activated receptors and induce the various signaling pathways. The Shc- and/or Grb2-activated mitogen-activated protein kinase (MAPK) pathway is a common target downstream of all ErbB receptors. Similarly, the phosphatidylinositol-3-kinase (PI-3K) pathway is directly or indirectly activated by most ErbBs. Several cytoplasmic docking proteins appear to be recruited by specific ErbB receptors and less exploited by others. These include the adaptors Crk, Nck, the phospholipase C gamma (PLCgamma), the intracellular tyrosine kinase Src, or the Cbl E3 ubiquitin protein ligase.
Class
Environmental Information Processing; Signal transduction
BRITE hierarchy
Pathway map
ErbB signaling pathway
mdo04012

All organismsOrtholog table
Organism
Monodelphis domestica (opossum) [GN:mdo]
Gene
pro-epidermal growth factor-like; K04357 epidermal growth factor [KO:K04357]
protransforming growth factor alpha-like; K08774 transforming growth factor, alpha [KO:K08774]
amphiregulin-like; K09782 amphiregulin [KO:K09782]
EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
ERBB2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) [KO:K05083] [EC:2.7.10.1]
PLCG1; phospholipase C, gamma 1 [KO:K01116] [EC:3.1.4.11]
PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) [KO:K05859] [EC:3.1.4.11]
calcium/calmodulin-dependent protein kinase type II subunit delta-like; K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] [KO:K04515] [EC:2.7.11.17]
CAMK2G; calcium/calmodulin-dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
CAMK2B; calcium/calmodulin-dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]
calcium/calmodulin-dependent protein kinase type II subunit alpha-like; K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] [KO:K04515] [EC:2.7.11.17]
protein kinase C beta type-like; K02677 classical protein kinase C [EC:2.7.11.13] [KO:K02677] [EC:2.7.11.13]
protein kinase C alpha type-like; K02677 classical protein kinase C [EC:2.7.11.13] [KO:K02677] [EC:2.7.11.13]
e3 ubiquitin-protein ligase CBL-like; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] [KO:K04707] [EC:6.3.2.19]
signal transduction protein CBL-C-like; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] [KO:K04707] [EC:6.3.2.19]
CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B [KO:K04707] [EC:6.3.2.19]
signal transducer and activator of transcription 5B-like; K11223 signal transducer and activator of transcription 5A [KO:K11223]
STAT5B; signal transducer and activator of transcription 5B [KO:K11224]
proto-oncogene tyrosine-protein kinase Src-like; K05704 tyrosine-protein kinase Src [EC:2.7.10.2] [KO:K05704] [EC:2.7.10.2]
PTK2; PTK2 protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]
adapter molecule crk-like; K04438 proto-oncogene C-crk [KO:K04438]
crk-like protein-like; K04438 proto-oncogene C-crk [KO:K04438]
ABL1; c-abl oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]
ABL2; v-abl Abelson murine leukemia viral oncogene homolog 2 [KO:K08887] [EC:2.7.10.2]
NCK1; NCK adaptor protein 1 [KO:K07365]
NCK2; NCK adaptor protein 2 [KO:K07365]
serine/threonine-protein kinase PAK 1-like; K04409 p21-activated kinase 1 [EC:2.7.11.1] [KO:K04409] [EC:2.7.11.1]
PAK2; p21 protein (Cdc42/Rac)-activated kinase 2 [KO:K04410] [EC:2.7.11.1]
serine/threonine-protein kinase PAK 3-like; K05733 p21-activated kinase 3 [EC:2.7.11.1] [KO:K05733] [EC:2.7.11.1]
PAK4; p21 protein (Cdc42/Rac)-activated kinase 4 [KO:K05734] [EC:2.7.11.1]
serine/threonine-protein kinase PAK 7-like; K05736 p21-activated kinase 7 [EC:2.7.11.1] [KO:K05736] [EC:2.7.11.1]
MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
dual specificity mitogen-activated protein kinase kinase 7-like; K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2] [KO:K04431] [EC:2.7.12.2]
MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
transcription factor AP-1-like; K04448 transcription factor AP-1 [KO:K04448]
ETS domain-containing protein Elk-1-like; K04375 ETS domain-containing protein Elk-1 [KO:K04375]
proheparin-binding EGF-like growth factor-like; K08523 heparin-binding EGF-like growth factor [KO:K08523]
proepiregulin-like; K09784 epiregulin [KO:K09784]
ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) [KO:K05084] [EC:2.7.10.1]
receptor tyrosine-protein kinase erbB-3-like; K05084 receptor tyrosine-protein kinase erbB-3 [EC:2.7.10.1] [KO:K05084] [EC:2.7.10.1]
NRG1; neuregulin 1 [KO:K05455]
pro-neuregulin-2; K05456 neuregulin 2 [KO:K05456]
ERBB4; v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) [KO:K05085] [EC:2.7.10.1]
SHC4; SHC (Src homology 2 domain containing) family, member 4 [KO:K06279]
SHC1; SHC (Src homology 2 domain containing) transforming protein 1 [KO:K06279]
SHC3; SHC (Src homology 2 domain containing) transforming protein 3 [KO:K06279]
growth factor receptor-bound protein 2-like; K04364 growth factor receptor-binding protein 2 [KO:K04364]
son of sevenless homolog 1-like; K03099 son of sevenless [KO:K03099]
SOS2; son of sevenless homolog 2 (Drosophila) [KO:K03099]
GTPase HRas-like; K02833 GTPase HRas [KO:K02833]
GTPase KRas-like; K07827 GTPase KRas [KO:K07827]
554186  
KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
554197  
NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog [KO:K07828]
BRAF; v-raf murine sarcoma viral oncogene homolog B1 [KO:K04365] [EC:2.7.11.1]
RAF proto-oncogene serine/threonine-protein kinase-like; K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] [KO:K04366] [EC:2.7.11.1]
MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
dual specificity mitogen-activated protein kinase kinase 2-like; K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] [KO:K04369] [EC:2.7.12.2]
mitogen-activated protein kinase 1-like; K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24] [KO:K04371] [EC:2.7.11.24]
MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
myc proto-oncogene protein-like; K04377 Myc proto-oncogene protein [KO:K04377]
GAB1; GRB2-associated binding protein 1 [KO:K09593]
NRG3; neuregulin 3 [KO:K05457]
pro-neuregulin-4; K05458 neuregulin 4 [KO:K05458]
phosphatidylinositol-4; K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] [KO:K00922] [EC:2.7.1.153]
phosphatidylinositol-4; K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] [KO:K00922] [EC:2.7.1.153]
phosphatidylinositol-4; K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] [KO:K00922] [EC:2.7.1.153]
PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha) [KO:K02649]
PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5 [KO:K02649]
phosphatidylinositol 3-kinase regulatory subunit beta-like; K02649 phosphoinositide-3-kinase, regulatory subunit [KO:K02649]
AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO:K04456] [EC:2.7.11.1]
RAC-alpha serine/threonine-protein kinase-like; K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] [KO:K04456] [EC:2.7.11.1]
AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) [KO:K04456] [EC:2.7.11.1]
ribosomal protein S6 kinase beta-2-like; K04688 p70 ribosomal S6 kinase [EC:2.7.11.1] [KO:K04688] [EC:2.7.11.1]
ribosomal protein S6 kinase beta-1-like; K04688 p70 ribosomal S6 kinase [EC:2.7.11.1] [KO:K04688] [EC:2.7.11.1]
eukaryotic translation initiation factor 4E-binding protein 1-like; K07205 eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]
bcl2 antagonist of cell death-like; K02158 BCL2-antagonist of cell death [KO:K02158]
GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
cyclin-dependent kinase inhibitor 1-like; K06625 cyclin-dependent kinase inhibitor 1A [KO:K06625]
Compound
C00076  
Calcium cation
C00165  
Diacylglycerol
C01245  
D-myo-Inositol 1,4,5-trisphosphate
C05981  
Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
Reference
  Authors
Yarden Y, Sliwkowski MX.
  Title
Untangling the ErbB signalling network.
  Journal
Nat Rev Mol Cell Biol 2:127-37 (2001)
Reference
  Authors
Citri A, Yarden Y.
  Title
EGF-ERBB signalling: towards the systems level.
  Journal
Nat Rev Mol Cell Biol 7:505-16 (2006)
Reference
  Authors
Scaltriti M, Baselga J.
  Title
The epidermal growth factor receptor pathway: a model for targeted therapy.
  Journal
Clin Cancer Res 12:5268-72 (2006)
Reference
  Authors
Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS.
  Title
Epidermal growth factor receptor (EGFR) signaling in cancer.
  Journal
Gene 366:2-16 (2006)
Reference
  Authors
Holbro T, Hynes NE.
  Title
ErbB receptors: directing key signaling networks throughout life.
  Journal
Annu Rev Pharmacol Toxicol 44:195-217 (2004)
Reference
  Authors
Liang J, Slingerland JM.
  Title
Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.
  Journal
Cell Cycle 2:339-45 (2003)
Reference
  Authors
Hynes NE, Lane HA.
  Title
ERBB receptors and cancer: the complexity of targeted inhibitors.
  Journal
Nat Rev Cancer 5:341-54 (2005)
Reference
  Authors
Oda K, Matsuoka Y, Funahashi A, Kitano H.
  Title
A comprehensive pathway map of epidermal growth factor receptor signaling.
  Journal
Mol Syst Biol 1:2005.0010 (2005)
Reference
  Authors
Schulze WX, Deng L, Mann M.
  Title
Phosphotyrosine interactome of the ErbB-receptor kinase family.
  Journal
Mol Syst Biol 1:2005.0008 (2005)
Reference
  Authors
Olayioye MA, Neve RM, Lane HA, Hynes NE.
  Title
The ErbB signaling network: receptor heterodimerization in development and cancer.
  Journal
EMBO J 19:3159-67 (2000)
Reference
PMID:9872057
  Authors
McCarty JH.
  Title
The Nck SH2/SH3 adaptor protein: a regulator of multiple intracellular signal transduction events.
  Journal
Bioessays 20:913-21 (1998)
Reference
  Authors
Clark DE, Williams CC, Duplessis TT, Moring KL, Notwick AR, Long W, Lane WS, Beuvink I, Hynes NE, Jones FE.
  Title
ERBB4/HER4 potentiates STAT5A transcriptional activity by regulating novel STAT5A serine phosphorylation events.
  Journal
J Biol Chem 280:24175-80 (2005)
Reference
  Authors
Muthuswamy SK, Gilman M, Brugge JS.
  Title
Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
  Journal
Mol Cell Biol 19:6845-57 (1999)
Reference
PMID:9642287
  Authors
Hashimoto Y, Katayama H, Kiyokawa E, Ota S, Kurata T, Gotoh N, Otsuka N, Shibata M, Matsuda M.
  Title
Phosphorylation of CrkII adaptor protein at tyrosine 221 by epidermal growth factor receptor.
  Journal
J Biol Chem 273:17186-91 (1998)
KO pathway
 

DBGET integrated database retrieval system